Integrated analyses of growth differentiation factor-15 concentration and cardiometabolic diseases in humans
Standard
Integrated analyses of growth differentiation factor-15 concentration and cardiometabolic diseases in humans. / Lemmelä, Susanna; Wigmore, Eleanor M; Benner, Christian; Havulinna, Aki S; Ong, Rachel M Y; Kempf, Tibor; Wollert, Kai C; Blankenberg, Stefan; Zeller, Tanja; Peters, James E; Salomaa, Veikko; Fritsch, Maria; March, Ruth; Palotie, Aarno; Daly, Mark; Butterworth, Adam S; Kinnunen, Mervi; Paul, Dirk S; Matakidou, Athena.
in: ELIFE, Jahrgang 11, e76272, 02.08.2022.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Integrated analyses of growth differentiation factor-15 concentration and cardiometabolic diseases in humans
AU - Lemmelä, Susanna
AU - Wigmore, Eleanor M
AU - Benner, Christian
AU - Havulinna, Aki S
AU - Ong, Rachel M Y
AU - Kempf, Tibor
AU - Wollert, Kai C
AU - Blankenberg, Stefan
AU - Zeller, Tanja
AU - Peters, James E
AU - Salomaa, Veikko
AU - Fritsch, Maria
AU - March, Ruth
AU - Palotie, Aarno
AU - Daly, Mark
AU - Butterworth, Adam S
AU - Kinnunen, Mervi
AU - Paul, Dirk S
AU - Matakidou, Athena
N1 - © 2022, Lemmelä, Wigmore et al.
PY - 2022/8/2
Y1 - 2022/8/2
N2 - Growth differentiation factor-15 (GDF15) is a stress response cytokine that is elevated in several cardiometabolic diseases and has attracted interest as a potential therapeutic target. To further explore the association of GDF15 with human disease, we conducted a broad study into the phenotypic and genetic correlates of GDF15 concentration in up to 14,099 individuals. Assessment of 772 traits across 6610 participants in FINRISK identified associations of GDF15 concentration with a range of phenotypes including all-cause mortality, cardiometabolic disease, respiratory diseases and psychiatric disorders, as well as inflammatory markers. A meta-analysis of genome-wide association studies (GWAS) of GDF15 concentration across three different assay platforms (n=14,099) confirmed significant heterogeneity due to a common missense variant (rs1058587; p.H202D) in GDF15, potentially due to epitope-binding artefacts. After conditioning on rs1058587, statistical fine mapping identified four independent putative causal signals at the locus. Mendelian randomisation (MR) analysis found evidence of a causal relationship between GDF15 concentration and high-density lipoprotein (HDL) but not body mass index (BMI). Using reverse MR, we identified a potential causal association of BMI on GDF15 (IVW pFDR = 0.0040). Taken together, our data derived from human population cohorts do not support a role for moderately elevated GDF15 concentrations as a causal factor in human cardiometabolic disease but support its role as a biomarker of metabolic stress.
AB - Growth differentiation factor-15 (GDF15) is a stress response cytokine that is elevated in several cardiometabolic diseases and has attracted interest as a potential therapeutic target. To further explore the association of GDF15 with human disease, we conducted a broad study into the phenotypic and genetic correlates of GDF15 concentration in up to 14,099 individuals. Assessment of 772 traits across 6610 participants in FINRISK identified associations of GDF15 concentration with a range of phenotypes including all-cause mortality, cardiometabolic disease, respiratory diseases and psychiatric disorders, as well as inflammatory markers. A meta-analysis of genome-wide association studies (GWAS) of GDF15 concentration across three different assay platforms (n=14,099) confirmed significant heterogeneity due to a common missense variant (rs1058587; p.H202D) in GDF15, potentially due to epitope-binding artefacts. After conditioning on rs1058587, statistical fine mapping identified four independent putative causal signals at the locus. Mendelian randomisation (MR) analysis found evidence of a causal relationship between GDF15 concentration and high-density lipoprotein (HDL) but not body mass index (BMI). Using reverse MR, we identified a potential causal association of BMI on GDF15 (IVW pFDR = 0.0040). Taken together, our data derived from human population cohorts do not support a role for moderately elevated GDF15 concentrations as a causal factor in human cardiometabolic disease but support its role as a biomarker of metabolic stress.
KW - Biomarkers
KW - Body Mass Index
KW - Cardiovascular Diseases/genetics
KW - Genome-Wide Association Study
KW - Humans
KW - Mendelian Randomization Analysis
U2 - 10.7554/eLife.76272
DO - 10.7554/eLife.76272
M3 - SCORING: Journal article
C2 - 35916366
VL - 11
JO - ELIFE
JF - ELIFE
SN - 2050-084X
M1 - e76272
ER -